Hester acquires technology from ICAR – NIHSAD to develop Low Pathogenic Avian Influenza (H9N2… EP News Bureau Dec 28, 2022 The disease generally has low mortality rate up to six per cent, but can increase significantly in the presence of other…
Hester signs deal ICAR – IVRI for technology to develop Brucella Abortus S19 Delta per Vaccine EP News Bureau Sep 23, 2020 Hopes to launch the vaccine in 18 months
